News

January 22, 2021

Factor Bioscience Profile

Brief version of a profile of a Cambridge, MA, company doing research and manufacture of MRNA technology that will slow and even reverse the aging process in human beings.

Read More

More News

January 13, 2022

Brooklyn ImmunoTherapeutics Provides Update on Regenerative Medicine Intellectual Property Portfolio

October 25, 2021

Factor Bioscience Joins Strategic Partner Brooklyn ImmunoTherapeutics to Ring the Nasdaq Closing Bell

October 21, 2021

Exacis Biotherapeutics Announces Strategic Partnership With CCRM For Specialty Manufacturing Of Services And Investment For Development Of iPSC-Derived mRNA-Engineered NK Cells

September 15, 2021

Brooklyn ImmunoTherapeutics to Participate in Grand Opening of Cambridge-Based mRNA Cleanroom Facility Shared with Factor Bioscience

September 9, 2021

Factor Bioscience Celebrates 10th Anniversary with Grand Opening of ISO Class 7 Cleanroom Facility in Cambridge, Massachusetts

View all News